Sumner Group Health is currently working in partnership with Sumner Group Health R&D and leading UK scientific institutions to develop its very own COVID-19 vaccine. The new Sumner vaccine  will support both Sumner Group Health’s commercial endeavours to deliver COVID 19 vaccine to the developing world as well as The Sumner Foundation whose vision it is to vaccinate refugee populations across The Middle East, North & Sub Saharan Africa and South East Asia. 
Sumner Group Health has existing  relationships with global vaccine manufacturers today. These relationships  allow the procurement and resale of vaccines into pre- approved markets around the world in the interim between now and successfully launching the SGH vaccine.